UnitedHealth Group (NYSE:UNH) Releases FY 2025 Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 29.500-30.000 for the period, compared to the consensus earnings per share estimate of 29.950. The company issued revenue guidance of $450.0 billion-$455.0 billion, compared to the consensus revenue estimate of $430.4 billion. UnitedHealth Group also updated its FY25 guidance to $29.50-$30.00 EPS.

Analyst Ratings Changes

Several brokerages recently issued reports on UNH. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Stephens reduced their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Finally, TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $621.58.

UnitedHealth Group Stock Down 0.5 %

Shares of UnitedHealth Group stock opened at $605.23 on Wednesday. The company has a market cap of $556.98 billion, a price-to-earnings ratio of 39.43, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The company’s 50 day moving average is $586.72 and its 200 day moving average is $557.83. UnitedHealth Group has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.